Mettler-Toledo International, Inc. $MTD Stock: Boston Trust Walden Corp Trims Stake

Boston Trust Walden Corp cut its holdings in Mettler-Toledo International, Inc. (NYSE:MTD) by 3.4% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 81,483 shares of the medical instruments supplier’s stock after selling 2,903 shares during the period. Mettler-Toledo International comprises approximately 1.0% of Boston Trust Walden Corp’s holdings, making the stock its 15th biggest position. Boston Trust Walden Corp owned 0.41% of Mettler-Toledo International worth $123,117,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of MTD. Chicago Partners Investment Group LLC raised its stake in Mettler-Toledo International by 11.7% during the third quarter. Chicago Partners Investment Group LLC now owns 344 shares of the medical instruments supplier’s stock worth $575,000 after acquiring an additional 36 shares during the period. AIA Group Ltd lifted its holdings in Mettler-Toledo International by 36.1% in the third quarter. AIA Group Ltd now owns 22,774 shares of the medical instruments supplier’s stock worth $34,410,000 after acquiring an additional 6,037 shares during the last quarter. Provenance Wealth Advisors LLC bought a new position in Mettler-Toledo International in the third quarter worth about $54,000. Torray Investment Partners LLC boosted its stake in Mettler-Toledo International by 0.7% in the third quarter. Torray Investment Partners LLC now owns 1,683 shares of the medical instruments supplier’s stock valued at $2,543,000 after acquiring an additional 12 shares during the period. Finally, Garde Capital Inc. acquired a new position in Mettler-Toledo International in the third quarter valued at approximately $227,000. 95.07% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on MTD. Wells Fargo & Company upped their target price on Mettler-Toledo International from $1,225.00 to $1,450.00 and gave the company an “equal weight” rating in a report on Monday, August 3rd. Morgan Stanley boosted their price objective on Mettler-Toledo International from $1,450.00 to $1,575.00 and gave the company an “equal weight” rating in a research report on Tuesday, October 13th. Barclays boosted their price objective on Mettler-Toledo International from $1,575.00 to $1,700.00 and gave the company an “overweight” rating in a research report on Wednesday, October 7th. Rothschild & Co Redburn assumed coverage on Mettler-Toledo International in a research note on Wednesday, September 2nd. They set a “sell” rating and a $1,200.00 price objective for the company. Finally, Stifel Nicolaus increased their target price on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a “buy” rating in a research report on Monday, August 3rd. Six analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $1,469.15.

Mettler-Toledo International Trading Up 1.5%

Shares of NYSE:MTD opened at $1,723.17 on Thursday. The company has a market cap of $34.53 billion, a PE ratio of 37.83, a P/E/G ratio of 3.42 and a beta of 1.16. The company’s 50-day moving average price is $1,512.80 and its 200 day moving average price is $1,343.25. Mettler-Toledo International, Inc. has a fifty-two week low of $1,023.05 and a fifty-two week high of $1,737.99. The company has a quick ratio of 0.78, a current ratio of 1.12 and a debt-to-equity ratio of 159.45.

Insider Buying and Selling

In other Mettler-Toledo International news, CEO Patrick Kaltenbach sold 942 shares of the company’s stock in a transaction dated Thursday, August 27th. The shares were sold at an average price of $1,425.00, for a total value of $1,342,350.00. Following the completion of the transaction, the chief executive officer owned 4,480 shares in the company, valued at approximately $6,384,000. This represents a 17.37% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 0.71% of the company’s stock.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc (NYSE: MTD) develops and manufactures precision instruments and related services for laboratory, industrial, and retail applications. Its products help customers weigh, measure, analyze, inspect, and control materials and processes with high accuracy.

The company’s laboratory offerings include balances and scales, analytical instruments, titration and pH systems, thermal analysis equipment, spectroscopy products, laboratory automation solutions, and associated software.